Latest News

The use of 5T prostate MRI offered significantly higher signal-to-noise ratio (SNR) than 3T prostate MRI as well as enhanced delineation with T2-weighted and diffusion-weighted imaging, according to newly published comparative research.

Catch up on the top AI-related news and research in radiology over the past month.

Whether it’s a home gym, a healthy diet or a prudent approach to savings and eventual retirement, there are key ‘assets’ that can help sustain a strong quality of life.

Catch up on the top radiology content of the past week.

Catch up on a variety of new FDA clearances in radiology from the past week.

Sharing his insights as well as findings from recent research, Mina Makary, M.D., discussed pertinent challenges with diversity and resident attrition rates in interventional radiology and possible approaches to address these issues.

A prospective research comparison of ultra-low-dose (ULD) PCCT and low-dose (LD) PCCT protocols yielded comparable image quality and strong agreement on emphysema severity assessments with ULD PCCT offering significantly reduced radiation dosing.

Employing low pressure ultrasound treatment to break up kidney stones, the Break Wave lithotripsy device offers a non-invasive, anesthesia-free alternative

In recent interviews, Rajesh Bhayana, M.D., Manisha Bahl, M.D., and Jeremie Calais, M.D., Ph.D., shared their thoughts on agentic AI, key directions in breast imaging research and emerging trends with prostate cancer theranostics in 2026.

In a prospective comparison with prior criteria for evaluating hepatocellular carcinoma surveillance, the American Association for the Study of Liver Diseases (AASLD) version 2023 system offered significantly higher sensitivity.

In a recent interview, Manisha Bahl, M.D., discussed recent research demonstrating a significant decline in the sensitivity of digital breast tomosynthesis (DBT) with increasing breast density as well as challenges in the utilization of supplemental imaging for women with dense breasts.

In a seven study meta-analysis with a total of 493 cases involving high-risk breast lesions, researchers found that contrast-enhanced breast MRI did not miss any cases of invasive breast cancer.

In a recent interview, David Yankelevitz, M.D., discussed the recent FDA clearance of the AI-CVD multisystem screening software and the ongoing evolution of incorporating computed tomography into personalized screening and risk assessments.